COURSE DEVELOPED FOR PEOPLE WITH INTELLECTUAL DISABILITY TO LEARN ABOUT RESEARCH Inclusive research used by Scope Australia to support advocacy for change through lived experience
With
Dr Caroline Hart,
Senior Research Officer
Scope Australia
Nell Buchanan,
Research Assistant
Scope Australia
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Melbourne | March 2026
Scope Australia is one of the largest not-for-profit disability service providers in Australia, supporting thousands of people with complex intellectual, physical, and multiple disabilities.
They operate across Victoria and New South Wales across more than 425 service locations.
Scope’s research team developed a course about what research is and how to do research. Eight people with intellectual disability did the course. Five people took part in interviews to help Scope learn about the course and how to make it better.
In November 2025, A/Professor Stella Koritsas, Scope’s Head of Research, Dr Caroline Hart, Senior Research Officer, and Mimari Hartono, Research Assistant, presented findings from their research into co-research as part of this week’s Australasian Society for Intellectual Disability 2025 conference — research carried out “with” or “by” people with disability rather than “to”, “about” or “for” them, which is important because it helps the sector uphold the United Nations Conventions on the Rights of Persons with Disabilities principles of dignity, autonomy, and full participation.
The research found that the course had a positive impact on people that extended beyond their ability to do and lead research. People who participated said that they felt more confident after the course and learned new skills. They also said that they made friends. They told Scope’s researchers that the course could be better if more easy English was used. They also wanted to be able to get to know people before the course started.
Australian Health Journal spoke with Dr Caroline Hart and Research Assistant Nell Buchanan, who explained what the courses means for the sector, plus the knowledge and experiences gained.
Source: Supplied and adapted
-
Continuing education program leads to better conversations
Medicines Australia’s Continuing Education Program (CEP) is designed to educate medical representatives to a recognised industry standard. Dr Tristan Ling, CEP Academic Lead and Project Manager at the College of Health and Medicine, University of Tasmania talks about the 900 students that come through the program each year.
The CEP is primarily directed at medical representatives working within the prescription medicines industry, but is also recommended to people who may not be currently employed within the industry but would like to pursue a career as a medical representative. It is also available to personnel working for organisations interacting with the pharmaceutical industry.
-
Understanding extracellular vesicles in cancer therapy research
Joy Wolfram is an Associate Professor at the Australian Institute for Bioengineering and Nanotechnology and the School of Chemical Engineering at the University of Queensland in Australia. Originally from Finland, she earned both her bachelor’s and master’s degrees in biology before transitioning to engineering with a PhD in nanotechnology completed in China. Wolfram has over a decade of experience working in hospitals in the United States before joining the University of Queensland.
Her research focuses on extracellular vesicles, which are crucial for cell communication both locally within tissues and over longer distances between organs. Her lab studies the roles of these vesicles in both health and disease, particularly in cancer. They investigate the harmful messages released by cancer cells that aid in tumour growth, specifically in breast cancer, while also exploring how to harness beneficial extracellular vesicles from healthy individuals as potential therapeutics.
-
Surgeon receives global award for kidney transplant science
Commencing a new series called Pioneers in Health Care, is an interview with Professor Jeremy Chapman AC who for over 40 years, has been involved in nephrectomy, or kidney transplantation.
Honoured “for eminent service to medicine, particularly in the areas of clinical and biomedical research, to the development of ethical policy and practices for organ donation, acquisition and transplantation, and to renal medicine organisations and publications, Jeremy Chapman AC has played significant roles in development of kidney, pancreas and unrelated Bone Marrow Transplantation in Australia.
